Copovidone (PVP-VA) Market Report 2026

Copovidone (PVP-VA) Market Overview

• Copovidone (PVP-VA) market size has reached to $1.08 billion in 2025 • Expected to grow to $1.67 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Rising Demand For Biopharmaceuticals Fueling The Growth Of The Market Due To Need For Advanced Targeted Therapies • Market Trend: Nitrite-Tested Grades Enhance Drug Safety And Regulatory Compliance • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Copovidone (PVP-VA) Market?

Copovidone (PVP-VA) is a synthetic polymer made from vinylpyrrolidone and vinyl acetate, known for its excellent solubility and film-forming properties. It is widely used to enhance the stability, bioavailability, and uniformity of active ingredients in formulations. Its versatility and compatibility with various compounds make it a key excipient in modern pharmaceutical and nutraceutical products. The main types of the copovidone (pvp-va) market include Copovidone, PVP-VA 64, and PVP-VA 73. Copovidone refers to a synthetic copolymer of vinylpyrrolidone and vinyl acetate that is widely used as a binder, film-former, and solubilizer in pharmaceutical formulations due to its excellent compressibility, stability, and ability to enhance the bioavailability of poorly soluble drugs, making it a critical excipient across solid and liquid dosage forms. There are product forms such as powder and liquid. The key applications include pharmaceuticals, cosmetics, food and beverage, adhesives, and coatings, And the main distribution channels include direct sales, distributors, and online retailers.

What Is The Copovidone (PVP-VA) Market Growth Forecast?

The copovidone (PVP-VA) market size is expected to see strong growth in the next few years. It will grow to $1.67 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to rising growth in cosmetics and personal-care formulations using versatile polymers, increasing interest in multifunctional excipients for food, nutraceutical and industrial applications, growing regulatory acceptance and quality standards favouring copovidone, and increasing investments in novel formulations leveraging copovidone. Major trends in the forecast period include advancement in use of copovidone for poorly water-soluble drugs via hot-melt extrusion and spray‐drying, innovation in controlled-release and solvent-free drug formulations, integration of copovidone in nutraceutical and cosmeceutical products, advancement of regulatory harmonisation facilitating global distribution, and innovation in multifunctional excipient blends combining copovidone with other polymers.

Global Copovidone (PVP-VA) Market Segmentation

1) By Type: Copovidone, PVP-VA 64, PVP-VA 73 2) By Product Form: Powder, Liquid 3) By Application: Pharmaceuticals, Cosmetics, Food And Beverage, Adhesives, Coatings 4) By Distribution Channel: Direct Sales, Distributors, Online Retailers Subsegments: 1) By Copovidone: Direct Compression Grade, Wet Granulation Grade, Film-Forming Grade, Sustained-Release Applications, Immediate-Release Applications 2) By PVP-VA 64: Tablet Binding Applications, Film-Coating Applications, Granulation Applications, Solubility-Enhancement Uses, Hot-Melt Extrusion Applications 3) By PVP-VA 73: High-Viscosity Formulations, Controlled-Release Systems, Solid Dispersion Formulations, Capsule Filling Applications, Stabilization Of Active Ingredients

What Are The Drivers Of The Copovidone (PVP-VA) Market?

The rising demand for biopharmaceuticals is expected to propel the growth of the copovidone (PVP-VA) market going forward. Biopharmaceuticals refer to therapeutic products that are produced using biological sources or biotechnology methods rather than traditional chemical synthesis. The increasing demand for biopharmaceuticals is due to the rising prevalence of chronic and complex diseases, which drives the need for advanced targeted therapies that conventional drugs cannot effectively treat. Copovidone (PVP-VA) supports biopharmaceuticals demand by providing versatile formulation and stabilizing properties, making it ideal for advanced drug delivery systems. It enhances drug solubility, stability, and bioavailability, improving overall therapeutic effectiveness and supporting the growing need for innovative biopharmaceutical products. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, prescription drug outlays rose 11.4% in 2023 to $449.7 billion, accelerating from 7.8% growth in 2022. Therefore, the rising demand for biopharmaceuticals is driving the growth of the copovidone (PVP-VA) industry. The increasing prevalence of chronic diseases is expected to propel the growth of the copovidone (PVP-VA) market going forward. Chronic diseases are long-lasting health conditions that usually progress slowly over time, such as diabetes, heart disease, and arthritis, and often require ongoing medical attention and lifestyle management to control symptoms and prevent complications. Chronic diseases are increasing largely due to unhealthy lifestyles, including poor diet, physical inactivity, and smoking, which raise the risk of conditions such as diabetes, heart disease, and obesity. Copovidone (PVP-VA) aids in chronic disease management by serving as a versatile pharmaceutical excipient that improves the stability, solubility, and bioavailability of medications. It enhances treatment efficacy by enabling more consistent drug delivery, supporting patient adherence, and facilitating the development of advanced drug formulations for long-term disease control. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing prevalence of chronic diseases is driving the growth of the copovidone (PVP-VA) industry.

Key Players In The Global Copovidone (PVP-VA) Market

Major companies operating in the copovidone (pvp-va) market are BASF SE, Ashland Global Holdings Inc., Hangzhou Motto Science & Technology Co. Ltd., JRS Pharma GmbH & Co. KG, Boai NKY Pharmaceuticals Ltd., Anhui Sunhere Pharmaceutical Excipients Co. Ltd., Luxi Group Co. Ltd., Zhongbao Chemicals Co. Ltd., Autech Industry Co. Ltd., Huangshan Bonsun Pharmaceuticals Co. Ltd., Ningbo Inno Pharmchem Co. Ltd., Shanghai Yuking Water Soluble Material Technology Co. Ltd., Tianjin YR Chemspec Technology Co. Ltd., Star-Tech Specialty Products Co. Ltd., JH Nanhang Life Sciences Co. Ltd., Huzhou Sunflower Specialty Polymer Co. Ltd., Jiaozuo Zhongwei Special Products Pharmaceutical Co. Ltd., Ulanqab Kema New Material Co. Ltd., Sunfair PCS Polymer Material (Nanjing) Co. Ltd., Hefei Trendchem Co. Ltd.

Global Copovidone (PVP-VA) Market Trends and Insights

Major companies operating in the copovidone (PVP-VA) market are focusing on developing advanced product grades and services, such as nitrite-tested grades, to boost regulatory compliance, enhance drug safety, and reduce nitrosamine risk. Nitrite-tested grades refer to advanced quality assurance services for excipients where each delivered batch is tested for nitrites, a potential precursor to nitrosamines with results documented on the Certificate of Analysis. For instance, in August 2025, BASF SE, a Germany-based chemical and materials company, launched Kollidon Nitrite Tested (NT) grades. This is an advanced service tier designed to support customers’ nitrosamine control strategies with enhanced nitrite testing and documentation for key products, including Kollidon VA 64 NT. The service provides nitrite tests on the respective product specification with results reported on the Certificate of Analysis (CoA) for all delivered batches, offering an additional layer of quality assurance and documentation.

Regional Insights

North America was the largest region in the copovidone (PVP-VA) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Copovidone (PVP-VA) Market?

The copovidone (PVP-VA) market consists of sales of bwf pharma copovidone, ashland copovidone klucel, basf copovidone vinol, cipla copovidone excipient, and dr. reddy’s copovidone powder. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Copovidone (PVP-VA) Market Report 2026?

The copovidone (pvp-va) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the copovidone (pvp-va) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.